Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content


Peru signs deal to purchase 12 million additional doses of Pfizer vaccine

2 minute read

Vials of the Pfizer-BioNTech Comirnaty coronavirus disease (COVID-19) vaccine are pictured in a General practitioners practice in Berlin, Germany, April 10, 2021. REUTERS/Fabrizio Bensch/File Photo

LIMA, May 5 (Reuters) - Peru President Francisco Sagasti announced on Wednesday a fresh deal with Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) to purchase an additional 12 million doses of their vaccine against COVID-19 as a fierce second wave of the virus ravages the country.

The president said on social media the additional shots would be delivered by year's end.

Peru's vaccination drive has been slow to get started and fraught with allegations of corruption, with just under 4% of the population inoculated with at least one dose to date, according to a Reuters tabulation.

See graphic for COVID-19 vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/

Peru had previously signed a contract with Pfizer to purchase 20 million doses, some of which has begun to arrive in the Andean nation.

Reporting by Marco Aquino, writing by Dave Sherwood, editing by Chris Reese

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters